We are live on ! Find out more
PCM

Parsons Capital Management Portfolio holdings

AUM $2.21B
1-Year Est. Return 28.12%
This Fund
S&P 500
This Quarter Est. Return
+12.76%
1 Year Est. Return
+28.12%
3 Year Est. Return
+84.89%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.13%
AUM
$996M
AUM Growth
+$73M
Cap. Flow
-$4.39M
Cap. Flow %
-0.44%
Top 10 Hldgs %
32.34%
Holding
361
New
17
Increased
88
Reduced
159
Closed
12

Top Buys

Rank Stock Value
1
RLMD icon
Relmada Therapeutics
RLMD
+$11.1M
2
BMY icon
Bristol-Myers Squibb
BMY
+$3.4M
3
TFC icon
Truist Financial
TFC
+$2.17M
4
FENY icon
Fidelity MSCI Energy Index ETF
FENY
+$1.55M
5
IBM icon
IBM
IBM
+$1.33M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$6.06M
2
MMM icon
3M
MMM
+$6.04M
3
STI
SunTrust Banks, Inc.
STI
+$2.12M
4
STZ icon
Constellation Brands
STZ
+$1.69M
5
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$1.45M

Sector Composition

Rank Sector Weight
1 Technology 19.34%
2 Healthcare 13.59%
3 Financials 12.59%
4 Industrials 12.28%
5 Consumer Discretionary 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WELL icon
101
Welltower
WELL
$171B
$2.41M 0.24%
29,488
-286
-1% -$24.5K
BKNG icon
102
Booking.com
BKNG
$162B
$2.39M 0.24%
29,050
-425
-1% -$33.4K
GLD icon
103
SPDR Gold Trust
GLD
$141B
$2.38M 0.24%
16,617
+3,196
+24% +$447K
WAT icon
104
Waters Corp
WAT
$39.2B
$2.37M 0.24%
10,162
– –
BAC icon
105
Bank of America
BAC
$440B
$2.26M 0.23%
64,268
-49
-0.1% -$1.58K
LMT icon
106
Lockheed Martin
LMT
$134B
$2.26M 0.23%
5,812
-12
-0.2% -$4.61K
TFC icon
107
Truist Financial
TFC
$64.2B
$2.25M 0.23%
+40,036
New +$2.17M
CVS icon
108
CVS Health
CVS
$122B
$2.25M 0.23%
30,232
-69
-0.2% -$4.84K
TJX icon
109
TJX Companies
TJX
$178B
$2.2M 0.22%
35,957
+780
+2% +$46.1K
CME icon
110
CME Group
CME
$95.6B
$2.16M 0.22%
10,749
-200
-2% -$41K
OMC icon
111
Omnicom Group
OMC
$23.2B
$2.13M 0.21%
26,225
-447
-2% -$35K
UL icon
112
Unilever
UL
$136B
$2.11M 0.21%
32,761
-483
-1% -$32.1K
SBUX icon
113
Starbucks
SBUX
$121B
$2.1M 0.21%
23,823
-138
-0.6% -$11.8K
DGRO icon
114
iShares Core Dividend Growth ETF
DGRO
$43.5B
$2.08M 0.21%
49,452
+3,670
+8% +$148K
EWBC icon
115
East-West Bancorp
EWBC
$18.1B
$2.06M 0.21%
42,225
-2,800
-6% -$126K
TD icon
116
Toronto Dominion Bank
TD
$200B
$2.04M 0.21%
36,432
-795
-2% -$45.1K
VAW icon
117
Vanguard Materials ETF
VAW
$3.13B
$1.95M 0.2%
14,550
+2,916
+25% +$376K
WAL icon
118
Western Alliance Bancorporation
WAL
$8.95B
$1.91M 0.19%
33,514
-679
-2% -$34.7K
BDX icon
119
Becton Dickinson
BDX
$48.4B
$1.82M 0.18%
6,869
-51
-0.7% -$12.7K
GGG icon
120
Graco
GGG
$13.5B
$1.8M 0.18%
34,572
– –
SO icon
121
Southern Company
SO
$107B
$1.78M 0.18%
28,013
-290
-1% -$18K
TXN icon
122
Texas Instruments
TXN
$260B
$1.77M 0.18%
13,820
-20
-0.1% -$2.47K
CMI icon
123
Cummins
CMI
$88.4B
$1.76M 0.18%
9,852
+103
+1% +$18.1K
UNP icon
124
Union Pacific
UNP
$175B
$1.73M 0.17%
9,543
-160
-2% -$27.4K
ACWX icon
125
iShares MSCI ACWI ex US ETF
ACWX
$11.8B
$1.72M 0.17%
35,050
+2,560
+8% +$122K
3 4
5
6 7

Similar funds

WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
IFA
Index Fund Advisors Irvine, California $2.22B AUM 20.66% 1-Year Est. Return
DPCM
Darlington Partners Capital Management Greenbrae, California $2.23B AUM 16.2% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.23B AUM 15.01% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
NP
NS Partners London, United Kingdom $2.23B AUM 20.03% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return

Parsons Capital Management's Q4 2019 Portfolio in Review

As of Q4 2019, Parsons Capital Management held 361 positions worth $996M, up 7.9% from $923M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Parsons Capital Management's Q4 2019 filing shows 17 new, 88 increased, 159 reduced and 12 closed positions. Its largest new stake was Relmada Therapeutics: 366,933 shares worth $14.3M. The largest sale was Celgene Corp, an estimated $6.06M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Parsons Capital Management's largest Q4 2019 buy was Relmada Therapeutics: 366,933 shares worth $14.3M.
  • Parsons Capital Management added most to Bristol-Myers Squibb in Q4 2019, an estimated $3.4M increase.
  • Parsons Capital Management's biggest Q4 2019 reduction was 3M, cutting an estimated $6.04M.
  • Parsons Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $6.06M.
  • Parsons Capital Management's ten largest holdings make up 32% of its $996M portfolio in Q4 2019.
  • Parsons Capital Management opened 17 new positions and closed 12 in Q4 2019.
  • Parsons Capital Management's portfolio value rose 7.9% quarter-over-quarter to $996M.

Based on Parsons Capital Management's 13F filing for Q4 2019, filed 3 Feb 2020.